Literature DB >> 9705748

Refined structure of the doubly intercalated d(TATAFBGCATA)2 aflatoxin B1 adduct.

W R Jones1, D S Johnston, M P Stone.   

Abstract

The refined solution structure for the 8, 9-dihydro-8-(N7-guanyl)-9-hydroxyaflatoxin B1 adduct was refined from the oligodeoxynucleotide duplex d(TATAFBGCATA)2 using a molecular dynamics protocol restrained by NOE data obtained from 1H NMR and compared with the refined structure of the unmodified oligomer, d(TATGCATA)2. The two aflatoxin B1 (AFB1) moieties were symmetry related by the pseudodyad axis of the self-complementary oligodeoxynucleotide. Each AFB1 intercalated into the helix above the 5'-face of the modified guanine, corroborating NMR spectroscopic data [Gopalakrishnan, S., Harris, T. M., and Stone, M. P. (1990) Intercalation of Aflatoxin B1 in Two Oligodeoxynucleotide Adducts: Comparative 1H NMR Analysis of d(ATCAFBGAT).d(ATCGAT) and d(ATAFBGCAT)2 Biochemistry 29, 10438-10448]. Molecular dynamics calculations restrained with 292 experimentally and empirically derived distances refined a family of structures characterized by pairwise root mean square differences of <1.3 A. Complete relaxation matrix calculations yielded a sixth root residual of 11 x 10(-2). Comparison of the refined structure with that of the corresponding unmodified oligodeoxynucleotide suggested that the two AFB1 adducts introduced a perturbation of the DNA localized at the two sites of adduction. The calculations predicted that each adduct introduced a "kink" into the DNA helical axis. However, the pseudodyad symmetry relating the two intercalation sites resulted in no net bending of the DNA. The results suggest the possibility that AFB1 lesions at adjacent guanines in the 5'-GC-3' sequence may be recognized or processed differently than are isolated AFB1 lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705748     DOI: 10.1021/tx980047m

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  7 in total

1.  Unraveling the aflatoxin-FAPY conundrum: structural basis for differential replicative processing of isomeric forms of the formamidopyrimidine-type DNA adduct of aflatoxin B1.

Authors:  Kyle L Brown; James Z Deng; Rajkumar S Iyer; Lalitha G Iyer; Markus W Voehler; Michael P Stone; Constance M Harris; Thomas M Harris
Journal:  J Am Chem Soc       Date:  2006-11-29       Impact factor: 15.419

Review 2.  Chemistry and structural biology of DNA damage and biological consequences.

Authors:  Michael P Stone; Hai Huang; Kyle L Brown; Ganesh Shanmugam
Journal:  Chem Biodivers       Date:  2011-09       Impact factor: 2.408

3.  The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.

Authors:  Maryann E Smela; Michelle L Hamm; Paul T Henderson; Constance M Harris; Thomas M Harris; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

4.  In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.

Authors:  Ahmad Besaratinia; Sang-In Kim; Pierre Hainaut; Gerd P Pfeifer
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

5.  Bypass of aflatoxin B1 adducts by the Sulfolobus solfataricus DNA polymerase IV.

Authors:  Surajit Banerjee; Kyle L Brown; Martin Egli; Michael P Stone
Journal:  J Am Chem Soc       Date:  2011-07-26       Impact factor: 15.419

6.  DNA Sequence Modulates Geometrical Isomerism of the trans-8,9- Dihydro-8-(2,6-diamino-4-oxo-3,4-dihydropyrimid-5-yl-formamido)- 9-hydroxy Aflatoxin B1 Adduct.

Authors:  Liang Li; Kyle L Brown; Ruidan Ma; Michael P Stone
Journal:  Chem Res Toxicol       Date:  2015-02-16       Impact factor: 3.739

7.  Structural perturbations induced by the alpha-anomer of the aflatoxin B(1) formamidopyrimidine adduct in duplex and single-strand DNA.

Authors:  Kyle L Brown; Markus W Voehler; Shane M Magee; Constance M Harris; Thomas M Harris; Michael P Stone
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.